Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases. Chen DM, et al. Among authors: paul c. Br J Dermatol. 2020 May;182(5):1111-1119. doi: 10.1111/bjd.18482. Epub 2019 Nov 28. Br J Dermatol. 2020. PMID: 31487383 Free PMC article. Clinical Trial.
Hyperkeratotic spicules and monoclonal gammopathy.
Paul C, Fermand JP, Flageul B, Caux F, Duterque M, Dubertret L, Aractingi S. Paul C, et al. J Am Acad Dermatol. 1995 Aug;33(2 Pt 2):346-51. doi: 10.1016/0190-9622(95)91431-5. J Am Acad Dermatol. 1995. PMID: 7615883 Review.
Ciclosporin in psoriasis clinical practice: an international consensus statement.
Griffiths CE, Dubertret L, Ellis CN, Finlay AY, Finzi AF, Ho VC, Johnston A, Katsambas A, Lison AE, Naeyaert JM, Nakagawa H, Paul C, Vanaclocha F. Griffiths CE, et al. Among authors: paul c. Br J Dermatol. 2004 May;150 Suppl 67:11-23. doi: 10.1111/j.0366-077X.2004.05949.x. Br J Dermatol. 2004. PMID: 15115441 Free article. Review.
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
Wolff K, Fleming C, Hanifin J, Papp K, Reitamo S, Rustin M, Shear N, Silny W, Korman N, Marks I, Cherill R, Emady-Azar S, Paul C; Multicentre Investigator Group. Wolff K, et al. Among authors: paul c. Br J Dermatol. 2005 Jun;152(6):1296-303. doi: 10.1111/j.1365-2133.2005.06674.x. Br J Dermatol. 2005. PMID: 15948996 Clinical Trial.
[Rituximab induced remission of pemphigus vulgaris: 2 cases].
Borel C, Launay F, Garrouste C, Astudillo L, Bazex J, Arlet P, Paul C, Viraben R, Sailler L. Borel C, et al. Among authors: paul c. Rev Med Interne. 2007 Apr;28(4):266-8. doi: 10.1016/j.revmed.2006.11.012. Epub 2006 Dec 8. Rev Med Interne. 2007. PMID: 17188405 French.
2,189 results